| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 5.504 | 12.384 | 14.801 | 25.685 | 17.597 | 22.551 |
| Total Income - EUR | - | - | - | 0 | 7.400 | 18.650 | 16.317 | 25.685 | 24.985 | 34.187 |
| Total Expenses - EUR | - | - | - | 3.394 | 7.067 | 13.756 | 14.456 | 24.706 | 24.144 | 33.234 |
| Gross Profit/Loss - EUR | - | - | - | -3.394 | 334 | 4.894 | 1.861 | 979 | 842 | 952 |
| Net Profit/Loss - EUR | - | - | - | -3.394 | 112 | 4.405 | 1.425 | 305 | 429 | 645 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Tdg Medtrade S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 170.251 | 164.006 | 219.883 | 229.918 | 236.551 | 226.436 | 212.335 |
| Current Assets | - | - | - | 1.119 | 1.498 | 3.183 | 378 | 125 | 832 | 471 |
| Inventories | - | - | - | 886 | 1.167 | 801 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 184 | 137 | 29 | 241 | 93 | 2 | 0 |
| Cash | - | - | - | 49 | 194 | 2.353 | 137 | 32 | 830 | 471 |
| Shareholders Funds | - | - | - | -3.351 | -3.174 | 1.181 | 2.581 | 2.894 | 3.315 | 3.941 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 174.721 | 168.678 | 221.884 | 227.715 | 233.781 | 223.953 | 208.864 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Tdg Medtrade S.r.l.